Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Freeport, IL
NPI: 1093913220Primary Practice Location
FHN MEMORIAL HOSPITAL
1045 W Stephenson St, Freeport, IL
Primary Employer
Fhn Memorial Hospital
fhn.org
HQ Phone
Get M.D. Arshad's Phone NumberMobile
Get M.D. Arshad's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 162 | 200 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 116 | 251 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 42 | 216 |
| 4 | 99202New patient office or other outpatient visit, typically 20 minutes | 35 | 35 |
| 5 | 77014Ct scan guidance for insertion of radiation therapy fields | 30 | 134 |
Targeting FLT3 Mutations in Acute Myeloid Leukemia: The Role of Quizartinib in Precision Medicine.
Authors: Kumbhare, Manoj, Chandak, Siddhi, Ide, Bhagwan, Dukare, Aishwarya, Velhal, Sakshi, Gode, Harshali, Pagere, Nishant, Shaikh, Arshad
Journal: Zhongguo Ying Yong Sheng Li Xue Za Zhi
Publication Date: 2025-06-03
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, BIOLOGICAL: Nivolumab, DRUG: Cisplatin, DRUG: Etoposide
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, PROCEDURE: Magnetic Resonance Imaging, BIOLOGICAL: Pembrolizumab, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, PROCEDURE: Computed Tomography, DRUG: Pemetrexed
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, DRUG: Atezolizumab, DRUG: Fluorouracil, PROCEDURE: Computed Tomography, DRUG: Oxaliplatin, DRUG: Leucovorin Calcium
